SIGA Technologies (NASDAQ: SIGA)
SIGA Technologies Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
SIGA Technologies Company Info
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The firm develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.
News & Analysis
Why SIGA Technologies Stock Fell 31.7% in September
The company has only one product: a monkeypox vaccine.
Better Monkeypox Stock: SIGA Technologies vs. Quest Diagnostics
One sells a treatment. The other sells a diagnostic test.
Is the Bubble Bursting for SIGA Technologies?
The stock has been crashing in recent weeks.
Could This Be the Next Big Meme Stock?
Not only is Siga's share price up, but trading volumes are through the roof.
Could SIGA Technologies Become the Next Moderna?
Shares of the company have jumped more than 60% in just the past month.
Is It Too Late to Buy SIGA Technologies Stock?
The stock skyrocketed last month.
Why Siga Technologies Stock Is Soaring Today
The drugmaker's smallpox drug may play a key role in combatting the global outbreak of monkeypox.
3 Monkeypox Stocks That Soared Last Week
Fear of another viral outbreak is generating a lot of buzz around these three biotech stocks.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.